表紙
市場調査レポート

世界の心臓バイオインプラント装置:市場予測・治験・M&A

Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A

発行 Renub Research 商品コード 270733
出版日 ページ情報 英文 284 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
世界の心臓バイオインプラント装置:市場予測・治験・M&A Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A
出版日: 2013年05月20日 ページ情報: 英文 284 Pages
概要

世界の心臓インプラント医療装置市場は、2010年から2017年の期間中に一桁の成長率が予測され、2017年までに270億米ドルを上回る見込みです・

当レポートでは、世界の心臓バイオインプラント市場の現状と将来的見通しについて調査分析し、セグメント、地域および主要企業別の市場分析と予測を提供しており、市場促進因子と課題、臨床試験の状況などをまとめ、概略以下の構成でお届けいたします。

第1章 エグゼクティブサマリー

第2章 世界の心臓バイオインプラント装置分析

  • 市場予測
  • 市場シェア&予測

第3章 植込み型除細動器(ICD)の分析

  • 世界のICD市場&予測
  • 世界のICD売上高&予測(数量別)
  • 米国 vs. 米国以外:ICD市場のシェア&予測
  • 企業(Boston Scientific, St Jude Medical, Medtronic & その他):ICD市場のシェア&予測

第4章 分植込み型除細動器(ICD)市場:数量&予測−米国&米国以外

  • 米国のICD市場&予測
  • 米国のICD売上高&予測(数量別)
  • 米国以外のICD市場&予測
  • 米国以外のICD売上高&予測(数量別)

第5章 植込み型除細動器(ICD)収益&予測:企業分析

  • Boston Scientific のICD収益&予測
  • St Jude MedicalのICD収益&予測
  • MedtronicのICD収益&予測
  • その他企業のICD収益&予測

第6章 植込み型心臓ペースメーカー(ICP)分析

  • 世界のICP市場・予測
  • 世界のICP売上高&予測(数量別)
  • 米国 vs. 米国以外:ICP市場のシェア&予測
  • 企業(Medtronic, Boston Scientific, St Jude Medical & その他):ICP市場のシェア&予測

第7章 植込み型心臓ペースメーカー(ICP):数量&予測−米国&米国以外

  • 米国のICP市場&予測
  • 米国のICP売上高&予測(数量別)
  • 米国以外のICP市場&予測
  • 米国以外のICP売上高&予測(数量別)

第8章 植込み型心臓ペースメーカー(ICP)収益&予測:企業分析

  • MedtronicのICD収益&予測
  • Boston Scientific のICD収益&予測
  • St Jude MedicalのICD収益&予測
  • その他企業のICD収益&予測

第9章 心臓弁の分析

  • 世界の心臓弁市場&予測
  • 世界の心臓弁売上高&予測(数量別)
  • アプリケーション別:心臓弁市場シェア&予測
  • 企業(Edwards Lifesciences, Medtronic, St. Jude Medical, ソーリングループ& その他):心臓弁市場シェア&予測

第10章 世界におけるアプリケーション別の心臓弁市場:数量&予測

  • 経カテーテル心臓弁市場&予測
  • 経カテーテル心臓弁売上高&予測(数量別)
  • 生体弁市場&予測
  • 生体弁売上高&予測(数量別)
  • 機械弁市場&予測
  • 機械弁売上高&予測(数量別)
  • 弁修復市場&予測
  • 弁修復売上高&予測(数量別)
  • Perceval Sutureless心臓弁市場&予測
  • Perceval Sutureless心臓弁売上高&予測(数量別)

第11章 心臓弁収益&予測:企業分析

  • 世界市場:Edwards Lifesciences の心臓弁収益&予測
  • 世界市場:Medtronicの心臓弁収益&予測
  • 世界市場:St Jude Medicalの心臓弁収益&予測
  • 世界市場:ソーリングループの心臓弁収益&予測
  • 世界市場:その他企業の心臓弁収益&予測

第12章 冠状動脈ステント分析

  • 世界の冠状動脈ステント市場&予測
  • 世界の冠状動脈ステント売上:数量別
  • 国別(米国・日本・欧州・その他)の冠状動脈ステント市場シェア&予測
  • アプリケーション別の冠状動脈ステント市場シェア&予測
  • 企業(Abbott Laboratories, Boston Scientific, Medtronic, Cordis Corporation) の冠状動脈ステント市場シェア&予測

第13章 冠状動脈ステントの国別市場シェア&予測

  • 米国の冠状動脈ステント市場&予測
  • 米国の冠状動脈ステント売上高&予測(数量別)
  • 欧州およびその他の冠状動脈ステント市場&予測
  • 欧州およびその他の冠状動脈ステント売上高&予測(数量別)
  • 日本の冠状動脈ステント市場&予測
  • 日本の冠状動脈ステント売上高&予測(数量別)

第14章 冠状動脈ステントのアプリケーション別(薬剤溶出ステント&ベアメタルステント)分析

  • 世界の薬剤溶出ステント市場&予測
  • 世界の薬剤溶出ステント売上高&予測(数量別)
  • 世界のベアメタルステント市場&予測
  • 世界のベアメタルステント売上高&予測(数量別)

第15章 冠状動脈ステントの企業別収益&予測

  • Abbott Laboratoriesの冠状動脈ステント収益&予測
  • Boston Scientificの冠状動脈ステント収益&予測
  • Medtronicの冠状動脈ステント収益&予測
  • Cordis Corporationの冠状動脈ステント収益&予測
  • その他企業の冠状動脈ステント収益&予測

第16章 末梢ステント分析

  • 世界の末梢ステント市場&予測
  • 世界の末梢ステント売上高&予測(数量別)
  • 世界の末梢ステント市場シェア&予測

第17章 末梢ステントのアプリケーション別売上高&予測

  • 世界の血管内ステントグラフト市場&予測
  • 世界の血管内ステントグラフト売上高&予測(数量別)
  • 世界の頚動脈ステント市場&予測
  • 世界の頚動脈ステント売上高&予測(数量別)
  • 世界の腎臓&関連ステント市場&予測
  • 世界の腎臓&関連ステント売上高&予測(数量別)
  • 世界の大腿部&関連ステント市場&予測
  • 世界の大腿部&関連ステント売上高&予測(数量別)

第18章 心室補助装置分析

  • 世界の心室補助装置市場&予測
  • 世界の心室補助装置売上高&予測(数量別)
  • 心室補助装置市場の国別シェア&予測
  • 心室補助装置市場のアプリケーション別シェア&予測

第19章 心室補助装置の国別市場&予測

  • 米国の心室補助装置市場
  • 米国の心室補助装置売上高&予測(数量別)
  • 米国以外の心室補助装置市場&予測
  • 米国以外の心室補助装置売上高&予測(数量別)

第20章 心室補助装置市場のアプリケーション別シェア&予測

  • 世界の左心室補助装置市場&予測
  • 世界の左心室補助装置売上高&予測(数量別)
  • 世界のその他VAD装置市場&予測
  • 世界のその他VAD装置売上高&予測(数量別)

第21章 企業パイプラインにおける心臓インプラント装置の治験状況

  • Edwards Lifesciences
  • St. Jude Medical
  • Boston Scientific
  • Medtronic
  • ソーリングループ
  • Abbott Laboratories

第22章 世界の心臓インプラント市場におけるM&A

第23章 心臓インプラント装置市場の成長促進因子

  • 心臓インプラント装置市場の影響を及ぼす傾向
  • 都市化と心臓病
  • 植込み型心臓装置の革新が支える心臓インプラント市場

第24章 心臓インプラント装置市場の課題

  • 心血管装置革新の重要性
  • 規制

図表リスト

目次

Abstract

Summary

The cardiac implant medical device market is forecasted to grow in single digit percent per year during 2010-2017 and is likely to exceed US$ 27 Billion by 2017. Growth in this sector is anticipated to grow despite continuing product recalls and safety controversies, particularly in the Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers segment. Product innovation, together with demographic structure of the world population, will play a pivotal role in the future growth of the market. Additionally, developing healthcare sector and advanced infrastructure along with infusion of new professional skills and expertise in emerging economies continue to propel long-term growth opportunities for manufacturers operating in the market.

Renub Research study titled "Global Cardiac Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A " provides a comprehensive assessment of the fast-evolving, high-growth global cardiac implant market. This 284 page report with 258 Figures and 24 Tables studies the Global Cardiac Implant Device Market. This report contains 24 chapters and has been bifurcate into 10 segments .

  • i) Worldwide Cardiac Implants Device Analysis (Chapter 2)
  • ii) Implantable Cardioverter Defibrillators (ICD) (Chapter 3 to 5)
  • iii) Implantable Cardiac Pacemakers (ICP) (Chapter 6 to 8)
  • iv) Heart Valve (Chapter 9 to 11)
  • v) Coronary Stent (Chapter 12 to 15)
  • vi) Perpheral Stent (Chapter 16 to 17)
  • vii) Ventricular Assist Device (Chapter 18 to 20)
  • viii) Cardiac Implants Devices Clinical Trial Statement (Chapter 21)
  • ix) Merger & Acquisitions (Chapter 22)
  • x) Growth Drivers & Challenges (Chapter 22 to 24)

All the above segments have been further sub divided into

  • a) Market & Forecast (2008 - 2017)
  • b) Sales Unit & Forecast (By Volume) (2008 - 2017)
  • c) Market Share & Forecast (2008 - 2017)
  • d) Companies Market Share & Forecast(2008 - 2017)
  • e) Companies Revenue & Forecast (2008 - 2017)
  • f) Clinical Trial Statement
  • g) Merger & Acquisition
  • h) Growth Driver & Challenges

The Following 24 Chapters Contains

  • First chapter is Executive Summary.
  • Second chapter contains worldwide cardiac implants device market, market share & forecast (2010 - 2017).
  • Third to Fifth chapter contains implantable cardioverter defibrillators (ICD) (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies' revenue & forecast) (2008 - 2017).
  • Sixth to Eighth chapter contains implantable cardiac pacemakers (ICP) (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies' revenue & forecast) (2008 - 2017).
  • Ninth to Eleventh chapter contains heart valve (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies' revenue & forecast) (2009-2017).
  • Twelfth to Fifteenth chapter contains coronary stent (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies' revenue & forecast) (2008-2017).
  • Sixteenth to Seventeenth chapter contains peripheral stent (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies' revenue & forecast) (2010-2017).
  • Eighteenth to nineteenth chapter contains ventricular assist device (market, sales unit/volume, market share, volume share, market forecast, volume forecast, geographic region & forecast, companies' revenue & forecast) (2010-2017).
  • Twentieth to Twenty Three chapters contains clinical trial statement, merger & acquisition, growth driver & challenges.

Company Analysis (By Segment) - Revenue & Forecast

Implantable Cardioverter Defibrillators (ICD) : Boston Scientific, St Jude Medical, Medtronic & Others

Implantable Cardiac Pacemakers (ICP) : Medtronic, Boston Scientific, St Jude Medical, & Others

Heart Valve : Edwards Lifesciences, Medtronic, St. Jude Medical, Sorin Group & Others

Coronary Stent : Abbott Laboratories, Boston Scientific, Medtronic, Cordis Corporation (Johnson & Johnson), Others

Geographic Region (By Countries) - Market, Sales Unit (Volume) & Forecast

Implantable Cardioverter Defibrillators (ICD) : Worldwide, United States & Rest of the World (ROW)

Implantable Cardiac Pacemakers (ICP) : Worldwide, United States & Rest of the World (ROW)

Heart Valve : Worldwide

Coronary Stent (Drug Eluting Stent & Bare Metal Stent) : Worldwide, United States, Japan, Europe & Rest of the World (ROW)

Peripheral Stent : Worldwide

Ventricular Assist Device : Worldwide, United States & Rest of World (ROW)

Clinical Trail Analysis - By Company

Edwards Lifesciences, St. Jude Medical, Boston Scientific , Medtronic, Sorin Group, Abbott Laboratories

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. Worldwide Cardiac Implants Device Analysis (2010 - 2017)

  • 2.1 Worldwide - Cardiac Implants Device Market & Forecast
  • 2.2 Worldwide - Cardiac Implants Device Market Share & Forecast

3. Implantable Cardioverter Defibrillators (ICD) Analysis (2008 - 2017)

  • 3.1 Worldwide - ICD Market & Forecast
  • 3.2 Worldwide - ICD Sales Unit & Forecast (By Volume)
  • 3.3 USA vs. Rest of World - ICD Market Share & Forecast
  • 3.4 Companies (Boston Scientific, St Jude Medical, Medtronic & Others) - ICD Market Share & Forecast

4. Implantable Cardioverter Defibrillators (ICD) Market, Volume & Forecast - USA & ROW (2008 - 2017)

  • 4.1 United States - ICD Market & Forecast
  • 4.2 United States - ICD Sales Unit & Forecast (By Volume)
  • 4.3 Rest of the World (ROW) - ICD Market & Forecast
  • 4.4 Rest of the World (ROW) - ICD Sales Unit & Forecast (By Volume)

5. Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast - Companies Analysis (2008 - 2017)

  • 5.1 Boston Scientific Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast
    • 5.1.1 Worldwide - Boston Scientific ICD Revenue & Forecast
    • 5.1.2 United States - Boston Scientific ICD Revenue & Forecast
    • 5.1.3 Rest of the World - Boston Scientific ICD Revenue & Forecast
  • 5.2 St Jude Medical Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast
    • 5.2.1 Worldwide - St Jude Medical ICD Revenue & Forecast
    • 5.2.2 United States - St Jude Medical ICD Revenue & Forecast
    • 5.2.3 Rest of the World - St Jude Medical ICD Revenue & Forecast
  • 5.3 Medtronic Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast
    • 5.3.1 Worldwide - Medtronic ICD Revenue & Forecast
    • 5.3.2 United States - Medtronic ICD Revenue & Forecast
    • 5.3.3 Rest of the World - Medtronic ICD Revenue & Forecast
  • 5.4 Other Companies Implantable Cardioverter Defibrillators (ICD) Revenue & Forecast
    • 5.4.1 Worldwide - Other Companies ICD Revenue & Forecast
    • 5.4.2 United States - Other Companies ICD Revenue & Forecast
    • 5.4.3 Rest of the World - Other Companies ICD Revenue & Forecast

6. Implantable Cardiac Pacemakers (ICP) Analysis (2008 - 2017)

  • 6.1 Worldwide - ICP Market & Forecast
  • 6.2 Worldwide - ICP Sales Unit & Forecast (By Volume)
  • 6.3 USA vs. Rest of World - ICP Market Share & Forecast
  • 6.4 Companies (Medtronic, Boston Scientific, St Jude Medical & Others) - ICP Market Share & Forecast

7. Implantable Cardiac Pacemakers (ICP) Market, Volume & Forecast (2008 - 2017)

  • 7.1 United States - ICP Market & Forecast
  • 7.2 United States - ICP Sales Unit & Forecast (By Volume)
  • 7.3 Rest of the World (ROW) - ICP Market & Forecast
  • 7.4 Rest of the World (ROW) - ICP Sales Unit & Forecast (By Volume)

8. Implantable Cardiac Pacemakers (ICP) Revenue & Forecast - Companies Analysis (2008 - 2017)

  • 8.1 Medtronic Implantable Cardiac Pacemakers (ICP) Revenue & Forecast
    • 8.1.1 Worldwide - Medtronic ICP Revenue & Forecast
    • 8.1.2 United States - Medtronic ICP Revenue & Forecast
    • 8.1.3 Rest of the World - Medtronic ICP Revenue & Forecast
  • 8.2 Boston Scientific Implantable Cardiac Pacemakers Revenue & Forecast
    • 8.2.1 Worldwide - Boston Scientific ICP Revenue & Forecast
    • 8.2.2 United States - Boston Scientific ICP Revenue & Forecast
    • 8.2.3 Rest of the World - Boston Scientific ICP Revenue & Forecast
  • 8.3 St Jude Medical Implantable Cardiac Pacemakers Revenue & Forecast
    • 8.3.1 Worldwide - St Jude Medical ICP Revenue & Forecast
    • 8.3.2 United States - St Jude Medical IPC Revenue & Forecast
    • 8.3.3 Rest of the World - St Jude Medical ICP Revenue & Forecast
  • 8.4 Other Companies ICP Revenue & Forecast
    • 8.4.1 Worldwide - Other Companies ICP Revenue & Forecast
    • 8.4.2 United States - Other Companies ICP Revenue & Forecast
    • 8.4.3 Rest of the World - Other Companies ICP Revenue & Forecast

9. Heart Valve Analysis (2009 - 2017)

  • 9.1 Worldwide - Heart Valve Market & Forecast
  • 9.2 Worldwide - Heart Valve Sales Unit & Forecast (By Volume)
  • 9.3 By Application - Heart Valve Market Share & Forecast
  • 9.4 Companies (Edwards Lifesciences, Medtronic, St. Jude Medical, Sorin Group & Others) - Heart Valve Market Share & Forecast

10. By Application (Worldwide) - Heart Valve Market, Volume & Forecast (2009 - 2017)

  • 10.1 Transcatheter Heart Valve Market & Forecast
    • 10.1.1 US FDA Approval of Sapien Transcatheter Heart Valve (THV)
    • 10.1.2 Competition Set to Increase with Pipeline of THV
    • 10.1.3 Technological Advances in THVR
    • 10.1.4 Favorable Reimbursement in Europe
  • 10.2 Transcatheter Heart Valve Sales Unit & Forecast (By Volume)
  • 10.3 Tissue Heart Valve Market & Forecast
  • 10.4 Tissue Heart Valve Sales Unit & Forecast (By Volume)
  • 10.5 Mechanical Heart Valve Market & Forecast
  • 10.6 Mechanical Heart Valve Sales Unit & Forecast (By Volume)
  • 10.7 Repair Heart Valve Market & Forecast
  • 10.8 Repair Heart Valve Sales Unit & Forecast (By Volume)
  • 10.9 Perceval Sutureless Heart Valve Market & Forecast
  • 10.10 Perceval Sutureless Heart Valve Sales Unit & Forecast (By Volume)

11. Heart Valve Revenue & Forecast - Companies Analysis (2009 - 2017)

  • 11.1 Worldwide - Edwards Lifesciences Heart Valve Revenue & Forecast
  • 11.2 Worldwide - Medtronic Heart Valve Revenue & Forecast
  • 11.3 Worldwide - St. Jude Medical Heart Valve Revenue & Forecast
  • 11.4 Worldwide - Sorin Group Heart Valve Revenue & Forecast
  • 11.5 Worldwide - Other Companies Heart Valve Revenue & Forecast

12. Coronary Stent Analysis (2008 - 2017)

  • 12.1 Worldwide - Coronary Stent Market & Forecast
  • 12.2 Worldwide - Coronary Stent Sales Unit - By Volume
  • 12.3 Countries (US, Japan, Europe & ROW) - Coronary Stent Market Share & Forecast
  • 12.4 By Application - Coronary Stent Market Share & Forecast
  • 12.5 Companies (Abbott Laboratories, Boston Scientific, Medtronic, Cordis Corporation) - Coronary Stent Market Share & Forecast

13. Countries - Coronary Stent Market & Forecast (2008 - 2017)

  • 13.1 United States - Coronary Stent Market & Forecast
  • 13.2 United States - Coronary Stent Sales Unit & Forecast (By Volume)
  • 13.3 Europe & Rest of the World (ROW) - Coronary Stent Market & Forecast
  • 13.4 Europe & Rest of the World (ROW) - Coronary Stent Sales Unit (By Volume)
  • 13.5 Japan - Coronary Stent Market & Forecast
  • 13.6 Japan - Coronary Stent Sales Unit & Forecast (By Volume)

14. By Application (Drug Eluting Stent & Bare Metal Stent) - Coronary Stent Analysis (2008 - 2017)

  • 14.1 Worldwide - Drug Eluting Stent Market & Forecast
    • 14.1.1 United States - Drug Eluting Stent Market & Forecast
    • 14.1.2 Europe & Rest of the World - Drug Eluting Stent Market & Forecast
    • 14.1.3 Japan - Drug Eluting Stent Market & Forecast
  • 14.2 Worldwide - Drug Eluting Stent Sales Unit & Forecast (By Volume)
    • 14.2.1 United States - Drug Eluting Stent Sales Unit & Forecast (By Volume)
    • 14.2.2 Europe & Rest of the World - Drug Eluting Stent Sales Unit & Forecast (By Volume)
    • 14.2.3 Japan - Drug Eluting Stent Sales Unit & Forecast (By Volume)
  • 14.3 Worldwide - Bare Metal Stent Market & Forecast
    • 14.3.1 United States - Bare Metal Stent Market & Forecast
    • 14.3.2 Europe & Rest of the World - Bare Metal Stent Market & Forecast
    • 14.3.3 Japan - Bare Metal Stent Market & Forecast
  • 14.4 Worldwide - Bare Metal Stent Sales Unit & Forecast (By Volume)
    • 14.4.1 United States - Bare Metal Stent Sales Unit & Forecast (By Volume)
    • 14.4.2 Europe & Rest of the World - Bare Metal Stent Sales Unit & Forecast (By Volume)
    • 14.4.3 Japan - Bare Metal Stent Sales Unit & Forecast (By Volume)

15. Companies - Coronary Stent Revenue & Forecast (2008 - 2017)

  • 15.1 Worldwide - Abbott Laboratories Coronary Stent Revenue & Forecast
    • 15.1.1 United States - Abbott Laboratories Coronary Stent Revenue & Forecast
    • 15.1.2 Europe & Rest of the World - Abbott Laboratories Coronary Stent Revenue & Forecast
    • 15.1.3 Japan - Abbott Laboratories Coronary Stent Revenue & Forecast
  • 15.2 Boston Scientific Coronary Stent Revenue & Forecast
    • 15.2.1 Worldwide - Boston Scientific Coronary Stent Revenue & Forecast
    • 15.2.2 United States - Boston Scientific Coronary Stent Revenue & Forecast
    • 15.2.3 Europe & Rest of the World - Boston Scientific Coronary Stent Revenue & Forecast
    • 15.2.4 Japan - Boston Scientific Coronary Stent Revenue & Forecast
  • 15.3 Medtronic Coronary Stent Revenue & Forecast
    • 15.3.1 Worldwide - Medtronic Coronary Stent Revenue & Forecast
    • 15.3.2 United States - Medtronic Coronary Stent Revenue & Forecast
    • 15.3.3 Europe & ROW - Medtronic Coronary Stent Revenue & Forecast
    • 15.3.4 Japan - Medtronic Coronary Stent Revenue & Forecast
  • 15.4 Cordis Corporation (Johnson & Johnson) Stent Revenue & Forecast
    • 15.4.1 Worldwide - Cordis Corporation Coronary Stent Revenue & Forecast
    • 15.4.2 United States - Cordis Corporation Coronary Stent Revenue
    • 15.4.3 Europe & Rest of the World - Cordis Corporation Coronary Stent Revenue
    • 15.4.4 Japan - Cordis Corporation Coronary Stent Revenue
  • 15.5 Other Companies Coronary Stent Revenue & Forecast
    • 15.5.1 Worldwide - Other Companies Coronary Stent Revenue & Forecast
    • 15.5.2 United States - Other Companies Coronary Stent Revenue & Forecast
    • 15.5.3 Europe & Rest of the World - Other Companies Coronary Stent Revenue & Forecast
      • 15.5.3.1 Japan - Other Companies Coronary Stent Revenue & Forecast

16. Peripheral Stent Analysis (2010 - 2017)

  • 16.1 Worldwide - Peripheral Stent Market & Forecast
  • 16.2 Worldwide - Peripheral Stent Sales Unit & Forecast (By Volume)
  • 16.3 Worldwide - Peripheral Stent Market Share & Forecast

17. By Application - Peripheral Stent Market, Sales Unit & Forecast (2010 - 2017)

  • 17.1 Worldwide - Endovascular Stent Graft Market & Forecast
  • 17.2 Worldwide - Endovascular Stent Graft Sales Unit & Forecast (By Volume)
  • 17.3 Worldwide - Carotid Stent Market & Forecast
  • 17.4 Worldwide - Carotid Stent Sales Unit & Forecast (By Volume)
  • 17.5 Worldwide - Renal & Related Stent Market & Forecast
  • 17.6 Worldwide - Renal & Related Stent Sales Unit & Forecast (By Volume)
  • 17.7 Worldwide - Femoral & Related Stent Market & Forecast
  • 17.8 Worldwide - Femoral & Related Stent Sales Unit & Forecast (By Volume)

18. Ventricular Assist Device Analysis (2010 - 2017)

  • 18.1 Worldwide - Ventricular Assist Device Market & Forecast
  • 18.2 Worldwide - Ventricular Assist Device Sales Unit & Forecast (By Volume)
  • 18.3 By Countries - Ventricular Assist Device Market Share & Forecast
  • 18.4 By Application - Ventricular Assist Device Market Share & Forecast

19. Countries - Ventricular Assist Device Market & Forecast (2010 - 2017)

  • 19.1 United States - Ventricular Assist Device Market
  • 19.2 United States - Ventricular Assist Device Sales Unit & Forecast (By Volume)
  • 19.3 Rest of the World - Ventricular Assist Device Market & Forecast
  • 19.4 Rest of the World - Ventricular Assist Device Sales Unit & Forecast (By Volume)

20. By Application - Ventricular Assist Device Market & Forecast (2010 - 2017)

  • 20.1 Worldwide - Left Ventricular Assist Device Market & Forecast
  • 20.2 Worldwide - Left Ventricular Assist Device Sales Unit & Forecast (By Volume)
  • 20.3 Worldwide - Other VAD Devices (Right VAD, Bi VAD & External VAD) Market & Forecast
  • 20.4 Worldwide - Other VAD Devices (Right VAD, Bi VAD & External VAD) Sales Unit & Forecast (By Volume)

21. Companies Pipeline Cardiac Implants Devices Clinical Trial Statement

  • 21.1 Edwards Lifesciences
    • 21.1.1 The Partner Trial: Placement of Aortic Transcatheter Valve Trial
    • 21.1.2 The Partner II Trial: Placement of Aortic Transcatheter Valves Trial
  • 21.2 St. Jude Medical
    • 21.2.1 Risk Stratification & Benefits with Cardiac Resynchronization Therapy (CRT)
    • 21.2.2 Comparison between Fractional Flow Reserve (FFR) Guided Revascularization versus Conventional Strategy in Acute ST-elevation Myocardial Infarction (STEMI) Patients with Multivessel Coronary Disease
    • 21.2.3 FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) plus Optimal Medical Treatment (OMT) verses Optimal Medical Treatment OMT Alone in Patients with Stable Coronary Artery Disease
  • 21.3 Boston Scientific
    • 21.3.1 Prevent: Promus BTK
    • 21.3.2 Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) Post Approval Registry
    • 21.3.3 Supernova Clinical Stenting Trial
    • 21.3.4 Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents (BESS)
  • 21.4 Medtronic
    • 21.4.1 Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
    • 21.4.2 Utility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillators
    • 21.4.3 Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System - The Engager European Pivotal Trial
    • 21.4.4 Adenosine Testing to Determine the Need for Pacing Therapy (ADEPT-ILR)
    • 21.4.5 Resolute Integrity US (RI-US)
  • 21.5 Sorin Group
    • 21.5.1 Efficacy of the ATP Switch Automatic Programming in Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) Implanted Patients
    • 21.5.2 Safety & Effectiveness Study of Perceval S Valve for Extended CE Mark (CAVALIER)
    • 21.5.3 Freedom SOLO Stentless Heart Valve
    • 21.5.4 Acute Optimization of Cardiac Resynchronization Therapy (CRT) Using Echocardiography and SonR (SonR Access)
  • 21.6 Abbott Laboratories
    • 21.6.1 Hybrid Sirolimus-Eluting Versus Everolimus-Eluting Stents for Total Coronary Occlusions (PRISON-IV)
    • 21.6.2 Study of the Orsiro Drug Eluting Stent System (BIOFLOW-II)

22. Merger & Acquisitions in Global Cardiac Implants Market

23. Growth Driver of Cardiac Implants Devices Market

  • 23.1 Habits Influencing the Cardiac Implants Devices Market
  • 23.2 Urbanization and Cardiovascular Diseases
  • 23.3 Innovation in Implantable Cardiac Devices Bolster Cardiac Implant Market

24. Challenges of Cardiac Implants Devices Market

  • 24.1 Significance of Cardiovascular Device Innovation
  • 24.2 Regulation

List of Figures:

  • Figure 2 1: Worldwide - Cardiac Implants Device Market (Million US$), 2010 - 2012
  • Figure 2 2: Worldwide - Forecast for Cardiac Implants Device Market (Million US$), 2013 - 2017
  • Figure 2 3: Worldwide - Cardiac Implants Device Market Share (Percent), 2010 - 2012
  • Figure 2 4: Worldwide - Forecast for Cardiac Implants Device Market Share (Percent), 2013 - 2017
  • Figure 3 1: Worldwide - Implantable Cardioverter Defibrillators Market (Million US$), 2008 - 2012
  • Figure 3 2: Worldwide - Forecast for Implantable Cardioverter Defibrillators Market (Million US$), 2013 - 2017
  • Figure 3 3: Worldwide - Implantable Cardioverter Defibrillators (ICD) Sales Unit (Thousand), 2008 - 2012
  • Figure 3 4: Worldwide - Forecast for Implantable Cardioverter Defibrillators (ICD) Sales Unit (Thousand), 2013 - 2017
  • Figure 3 5: Worldwide - Countries wise Implantable Cardioverter Defibrillators (ICD) Market Share (Percent), 2008 - 2012
  • Figure 3 6: Worldwide - Forecast for Countries wise Implantable Cardioverter Defibrillators (ICD) Market Share (Percent), 2013 - 2017
  • Figure 3 7: Worldwide - Companies Wise Implantable Cardioverter Defibrillators (ICD) Market Share (Percent), 2008 - 2012
  • Figure 3 8: Worldwide - Forecast for Companies Wise Implantable Cardioverter Defibrillators (ICD) Market Share (Percent), 2013 - 2017
  • Figure 4 1: United States - Implantable Cardioverter Defibrillators Market (Million US$), 2008 - 2012
  • Figure 4 2: United States - Forecast for Implantable Cardioverter Defibrillators Market (Million US$), 2013 - 2017
  • Figure 4 3: United States - Implantable Cardioverter Defibrillators (ICD) Sales Unit (Thousand), 2008 - 2012
  • Figure 4 4: United States - Forecast for Implantable Cardioverter Defibrillators (ICD) Sales Unit (Thousand), 2013 - 2017
  • Figure 4 5: Rest of the World - Implantable Cardioverter Defibrillators Market (Million US$), 2008 - 2012
  • Figure 4 6: Rest of the World - Forecast for Implantable Cardioverter Defibrillators Market (Million US$), 2013 - 2017
  • Figure 4 7: Rest of the World - Implantable Cardioverter Defibrillators (ICD) Sales Unit (Thousand), 2008 - 2012
  • Figure 4 8: Rest of the World - Forecast for Implantable Cardioverter Defibrillators (ICD) Sales Unit (Thousand), 2013 - 2017
  • Figure 5 1: Worldwide - Boston Scientific Implantable Cardioverter Defibrillators (ICD) Revenue (Million US$), 2008 - 2012
  • Figure 5 2: Worldwide - Forecast for Boston Scientific Implantable Cardioverter Defibrillators (ICD) Revenue (Million US$), 2013 - 2017
  • Figure 5 3: United States - Boston Scientific Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 - 2012
  • Figure 5 4: United States - Forecast for Boston Scientific Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 - 2017
  • Figure 5 5: Rest of the World - Boston Scientific Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 - 2012
  • Figure 5 6: Rest of the World - Forecast for Boston Scientific Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 - 2017
  • Figure 5 7: Worldwide - St Jude Medical Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 - 2012
  • Figure 5 8: Worldwide - Forecast for St Jude Medical Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 - 2017
  • Figure 5 9: United States - St Jude Medical Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 - 2012
  • Figure 5 10: United States - Forecast for St Jude Medical Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 - 2017
  • Figure 5 11: Rest of the World - St Jude Medical Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 - 2012
  • Figure 5 12: Rest of the World - Forecast for St Jude Medical Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 - 2017
  • Figure 5 13: Worldwide - Medtronic Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 - 2012
  • Figure 5 14: Worldwide - Forecast for Medtronic Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 - 2017
  • Figure 5 15: United States - Medtronic Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 - 2012
  • Figure 5 16: United States - Forecast for Medtronic Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 - 2017
  • Figure 5 17: Rest of the World - Medtronic Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 - 2012
  • Figure 5 18: Rest of the World - Forecast for Medtronic Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 - 2017
  • Figure 5 19: Worldwide - Other Companies Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 - 2012
  • Figure 5 20: Worldwide - Forecast for Other Companies Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 - 2017
  • Figure 5 21: United States - Other Companies Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 - 2012
  • Figure 5 22: United States - Forecast for Other Companies Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 - 2017
  • Figure 5 23: Rest of the World - Other Companies Implantable Cardioverter Defibrillators Revenue (Million US$), 2008 - 2012
  • Figure 5 24: Rest of the World - Forecast for Other Companies Implantable Cardioverter Defibrillators Revenue (Million US$), 2013 - 2017
  • Figure 6 1: Worldwide - Implantable Cardiac Pacemakers (ICP) Market (Million US$), 2008 - 2012
  • Figure 6 2: Worldwide - Forecast for Implantable Cardiac Pacemakers Market (Million US$), 2013 - 2017
  • Figure 6 3: Worldwide - Implantable Cardiac Pacemakers (ICP) Sales Unit (Thousand), 2008 - 2012
  • Figure 6 4: Worldwide - Forecast for Implantable Cardiac Pacemakers (ICP) Sales Unit (Thousand), 2013 - 2017
  • Figure 6 5: Worldwide - Countries wise Implantable Cardiac Pacemakers (ICP) Market Share (Percent), 2008 - 2012
  • Figure 6 6: Worldwide - Forecast for Countries wise Implantable Cardiac Pacemakers (ICP) Market Share (Percent), 2013 - 2017
  • Figure 6 7: Worldwide - Companies wise Implantable Cardiac Pacemakers (ICP) Market Share (Percent), 2008 - 2012
  • Figure 6 8: Worldwide - Forecast for Companies wise Implantable Cardiac Pacemakers (ICP) Market Share (Percent), 2013 - 2017
  • Figure 7 1: United States - Implantable Cardiac Pacemakers Market (Million US$), 2008 - 2012
  • Figure 7 2: United States - Forecast for Implantable Cardiac Pacemakers Market (Million US$), 2013 - 2017
  • Figure 7 3: United States - Implantable Cardiac Pacemakers (ICP) Sales Unit (Thousand), 2008 - 2012
  • Figure 7 4: United States - Forecast for Implantable Cardiac Pacemakers (ICP) Sales Unit (Thousand), 2013 - 2017
  • Figure 7 5: Rest of the World - Implantable Cardiac Pacemakers Market (Million US$), 2008 - 2012
  • Figure 7 6: Rest of the World - Forecast for Implantable Cardiac Pacemakers Market (Million US$), 2013 - 2017
  • Figure 7 7: Rest of the World - Implantable Cardiac Pacemakers (ICP) Sales Unit (Thousand), 2008 - 2012
  • Figure 7 8: Rest of the World - Forecast for Implantable Cardiac Pacemakers (ICP) Sales Unit (Thousand), 2013 - 2017
  • Figure 8 1: Worldwide - Medtronic Implantable Cardiac Pacemakers Revenue (Million US$), 2008 - 2012
  • Figure 8 2: Worldwide - Forecast for Medtronic Implantable Cardiac Pacemakers Revenue (Million US$), 2013 - 2017
  • Figure 8 3: United States - Medtronic Implantable Cardiac Pacemakers Revenue (Million US$), 2008 - 2012
  • Figure 8 4: United States - Forecast for Medtronic Implantable Cardiac Pacemakers Revenue (Million US$), 2013 - 2017
  • Figure 8 5: Rest of the World - Medtronic Implantable Cardiac Pacemakers Revenue (Million US$), 2008 - 2012
  • Figure 8 6: Rest of the World - Forecast for Medtronic Implantable Cardiac Pacemakers Revenue (Million US$), 2013 - 2017
  • Figure 8 7: Worldwide - Boston Scientific Implantable Cardiac Pacemakers Revenue (Million US$), 2008 - 2012
  • Figure 8 8: Worldwide - Forecast for Boston Scientific Implantable Cardiac Pacemakers Revenue (Million US$), 2013 - 2017
  • Figure 8 9: United States - Boston Scientific Implantable Cardiac Pacemakers Revenue (Million US$), 2008 - 2012
  • Figure 8 10: United States - Forecast for Boston Scientific Implantable Cardiac Pacemakers Revenue (Million US$), 2013 - 2017
  • Figure 8 11: Rest of the World - Boston Scientific Implantable Cardiac Pacemakers Revenue (Million US$), 2008 - 2012
  • Figure 8 12: Rest of the World - Forecast for Boston Scientific Implantable Cardiac Pacemakers Revenue (Million US$), 2013 - 2017
  • Figure 8 13: Worldwide - St Jude Medical Implantable Cardiac Pacemakers Revenue (Million US$), 2008 - 2012
  • Figure 8 14: Worldwide - Forecast for St Jude Medical Implantable Cardiac Pacemakers Revenue (Million US$), 2013 - 2017
  • Figure 8 15: United States - St Jude Medical Implantable Cardiac Pacemakers Revenue (Million US$), 2008 - 2012
  • Figure 8 16: United States - Forecast for St Jude Medical Implantable Cardiac Pacemakers Revenue (Million US$), 2013 - 2017
  • Figure 8 17: Rest of the World - St Jude Medical Implantable Cardiac Pacemakers Revenue (Million US$), 2008 - 2012
  • Figure 8 18: Rest of the World - Forecast for St Jude Medical Implantable Cardiac Pacemakers Revenue (Million US$), 2013 - 2017
  • Figure 8 19: Worldwide - Other Companies Implantable Cardiac Pacemakers Revenue (Million US$), 2008 - 2012
  • Figure 8 20: Worldwide - Forecast for Other Companies Implantable Cardiac Pacemakers Revenue (Million US$), 2013 - 2017
  • Figure 8 21: United States - Other Companies Implantable Cardiac Pacemakers Revenue (Million US$), 2008 - 2012
  • Figure 8 22: United States - Forecast for Other Companies Implantable Cardiac Pacemakers Revenue (Million US$), 2013 - 2017
  • Figure 8 23: Rest of the World - Other Companies Implantable Cardiac Pacemakers Revenue (Million US$), 2008 - 2012
  • Figure 8 24: Rest of the World - Forecast for Other Companies Implantable Cardiac Pacemakers Revenue (Million US$), 2013 - 2017
  • Figure 9 1: Worldwide - Heart Valve Market (Million US$), 2009 - 2012
  • Figure 9 2: Worldwide - Forecast for Heart Valve Market (Million US$), 2013 - 2017
  • Figure 9 3: Worldwide - Heart Valve Sales Unit (Thousand), 2009 - 2012
  • Figure 9 4: Worldwide - Forecast for Heart Valve Sales Unit (Thousand), 2013 - 2017
  • Figure 9 5: Worldwide - Application wise Heart Valve Market Share (Percent), 2009 - 2012
  • Figure 9 6: Worldwide - Forecast for Application wise Heart Valve Market Share (Percent), 2013 - 2017
  • Figure 9 7: Worldwide - Companies wise Heart Valve Market Share (Percent), 2009 - 2012
  • Figure 9 8: Worldwide - Forecast for Companies wise Heart Valve Market Share (Percent), 2013 -2017
  • Figure 10 1: Worldwide - Transcatheter Heart Valve Market (Million US$), 2009 - 2012
  • Figure 10 2: Worldwide - Forecast for Transcatheter Heart Valve Market (Million US$), 2013 -2017
  • Figure 10 3: Worldwide - Transcatheter Heart Valve Sales Unit (Thousand), 2009 - 2012
  • Figure 10 4: Worldwide - Forecast for Transcatheter Heart Valve Sales Unit (Thousand), 2013 - 2017
  • Figure 10 5: Worldwide - Tissue Heart Valve Market (Million US$), 2009 - 2012
  • Figure 10 6: Worldwide - Forecast for Tissue Heart Valve Market (Million US$), 2013 - 2017
  • Figure 10 7: Worldwide - Tissue Heart Valve Sales Unit (Thousand), 2009 - 2012
  • Figure 10 8: Worldwide - Forecast for Tissue Heart Valve Sales Unit (Thousand), 2013 - 2017
  • Figure 10 9: Worldwide - Mechanical Heart Valves Market (Million US$), 2009 - 2012
  • Figure 10 10: Worldwide - Forecast for Mechanical Heart Valves Market (Million US$), 2013 - 2017
  • Figure 10 11: Worldwide - Mechanical Heart Valves Sales Unit (Thousand), 2009 - 2012
  • Figure 10 12: Worldwide - Forecast for Mechanical Heart Valves Sales Unit (Thousand), 2013 - 2017
  • Figure 10 13: Worldwide - Repair Heart Valve Market (Million US$), 2009 - 2012
  • Figure 10 14: Worldwide - Forecast for Repair Heart Valve Market (Million US$), 2013 - 2017
  • Figure 10 15: Worldwide - Repair Heart Valve Sales Unit (Thousand), 2009 - 2012
  • Figure 10 16: Worldwide - Forecast for Repair Heart Valve Sales Unit (Thousand), 2013 - 2017
  • Figure 10 17: Worldwide -Sutureless Heart Valve Market & Forecast (Million US$), 2012 - 2017
  • Figure 10 18: Worldwide - Sutureless Heart Valve Sales Unit & Forecast (Thousand), 2012 - 2017
  • Figure 11 1: Worldwide - Edwards Lifesciences Heart Valve Revenue (Million US$), 2009 - 2012
  • Figure 11 2: Worldwide - Forecast for Edwards Lifesciences Heart Valve Revenue (Million US$), 2013 - 2017
  • Figure 11 3: Worldwide - Medtronic Heart Valve Revenue (Million US$), 2009 - 2012
  • Figure 11 4: Worldwide - Forecast for Medtronic Heart Valve Revenue (Million US$), 2013 - 2017
  • Figure 11 5: Worldwide - St Jude Medical Heart Valve Revenue (Million US$), 2009 - 2012
  • Figure 11 6: Worldwide - Forecast for St Jude Heart Valve Revenue (Million US$), 2013 - 2017
  • Figure 11 7: Worldwide - Sorin Group Heart Valve Revenue (Million US$), 2009 - 2012
  • Figure 11 8: Worldwide - Forecast for Sorin Group Heart Valve Revenue (Million US$), 2013 - 2017
  • Figure 11 9: Worldwide - Other Companies Heart Valve Revenue (Million US$), 2009 - 2012
  • Figure 11 10: Worldwide - Forecast for Other Companies Heart Valve Revenue (Million US$), 2013 - 2017
  • Figure 12 1: Worldwide - Coronary Stent Market (Million US$), 2008 - 2012
  • Figure 12 2: Worldwide - Forecast for Coronary Stent Market (Million US$), 2013 - 2017
  • Figure 12 3: Worldwide - Coronary Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 12 4: Worldwide - Forecast for Coronary Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 12 5: Worldwide - Countries wise Coronary Stent Market Share (Percent), 2008 - 2012
  • Figure 12 6: Worldwide - Forecast for Countries wise Coronary Stent Market Share (Percent), 2013 - 2017
  • Figure 12 7: Worldwide - Segment wise Coronary Stent Market Share (Percent), 2008 - 2012
  • Figure 12 8: Worldwide - Forecast for Segment wise Coronary Stent Market Share (Percent), 2013 - 2017
  • Figure 12 9: Worldwide - Companies wise Coronary Stent Market Share (Percent), 2008 - 2012
  • Figure 12 10: Worldwide - Forecast for Companies wise Coronary Stent Market Share (Percent), 2013 - 2017
  • Figure 13 1: United States - Coronary Stent Market (Million US$), 2008 - 2012
  • Figure 13 2: United States - Forecast for Coronary Stent Market (Million US$), 2013 - 2017
  • Figure 13 3: United States - Coronary Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 13 4: United States - Forecast for Coronary Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 13 5: Europe & ROW - Coronary Stent Market (Million US$), 2008 - 2012
  • Figure 13 6: Europe & ROW - Forecast for Coronary Stent Market (Million US$), 2013 - 2017
  • Figure 13 7: Europe & ROW - Coronary Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 13 8: Europe & ROW - Forecast for Coronary Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 13 9: Japan - Coronary Stent Market (Million US$), 2008 - 2012
  • Figure 13 10: Japan - Forecast for Coronary Stent Market (Million US$), 2013 - 2017
  • Figure 13 11: Japan - Coronary Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 13 12: Japan - Forecast for Coronary Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 14 1: Worldwide - Drug Eluting Stent Market (Million US$), 2008 - 2012
  • Figure 14 2: Worldwide - Forecast for Drug Eluting Stent Market (Million US$), 2013 - 2017
  • Figure 14 3: United States - Drug Eluting Stent Market (Million US$), 2008 - 2012
  • Figure 14 4: United States - Forecast for Drug Eluting Stent Market (Million US$), 2013 - 2017
  • Figure 14 5: Europe & ROW - Drug Eluting Stent Market (Million US$), 2008 - 2012
  • Figure 14 6: Europe & ROW - Forecast for Drug Eluting Stent Market (Million US$), 2013 - 2017
  • Figure 14 7: Japan - Drug Eluting Stent Market (Million US$), 2008 - 2012
  • Figure 14 8: Japan - Forecast for Drug Eluting Stent Market (Million US$), 2013 - 2017
  • Figure 14 9: Worldwide - Drug Eluting Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 14 10: Worldwide - Forecast for Drug Eluting Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 14 11: United States - Drug Eluting Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 14 12: United States - Forecast for Drug Eluting Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 14 13: Europe & ROW - Drug Eluting Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 14 14: Europe & ROW - Forecast for Drug Eluting Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 14 15: Japan - Drug Eluting Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 14 16: Japan - Forecast for Drug Eluting Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 14 17: Worldwide - Bare Metal Stent Market (Million US$), 2008 - 2012
  • Figure 14 18: Worldwide - Forecast for Bare Metal Stent Market (Million US$), 2013 - 2017
  • Figure 14 19: United States - Bare Metal Stent Market (Million US$), 2008 - 2012
  • Figure 14 20: United States - Forecast for Bare Metal Stent Market (Million US$), 2013 - 2017
  • Figure 14 21: Europe & ROW - Bare Metal Stent Market (Million US$), 2008 - 2012
  • Figure 14 22: Europe & ROW - Forecast for Bare Metal Stent Market (Million US$), 2013 - 2017
  • Figure 14 23: Japan - Bare Metal Stent Market (Million US$), 2008 - 2012
  • Figure 14 24: Japan - Forecast for Bare Metal Stent Market (Million US$), 2013 - 2017
  • Figure 14 25: Worldwide - Bare Metal Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 14 26: Worldwide - Forecast for Bare Metal Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 14 27: United States - Bare Metal Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 14 28: United States - Forecast for Bare Metal Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 14 29: Europe & ROW - Bare Metal Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 14 30: Europe & ROW - Forecast for Bare Metal Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 14 31: Japan - Bare Metal Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 14 32: Japan - Forecast for Bare Metal Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 15 1: Worldwide - Abbott Laboratories Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 2: Worldwide - Forecast for Abbott Laboratories Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 3: United States - Abbott Laboratories Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 4: United States - Forecast for Abbott Laboratories Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 5: Europe & ROW - Abbott Laboratories Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 6: Europe & ROW - Forecast for Abbott Laboratories Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 7: Japan - Abbott Laboratories Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 8: Japan - Forecast for Abbott Laboratories Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 9: Worldwide - Boston Scientific Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 10: Worldwide - Forecast for Boston Scientific Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 11: United States - Boston Scientific Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 12: United States - Forecast for Boston Scientific Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 13: Europe & Rest of the World - Boston Scientific Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 14: Europe & Rest of the World - Forecast for Boston Scientific Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 15: Japan - Boston Scientific Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 16: Japan - Forecast for Boston Scientific Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 17: Worldwide - Medtronic Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 18: Worldwide - Forecast for Medtronic Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 19: United States - Medtronic Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 20: United States - Forecast for Medtronic Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 21: Europe & ROW - Medtronic Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 22: Europe & ROW - Forecast for Medtronic Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 23: Japan - Medtronic Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 24: Japan - Forecast for Medtronic Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 25: Worldwide - Cordis Corporation Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 26: United States - Cordis Corporation Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 27: Europe & ROW - Cordis Corporation Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 28: Japan - Cordis Corporation Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 29: Worldwide - Other Companies Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 30: Worldwide - Forecast for Other Companies Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 31: United States - Other Companies Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 32: United States - Forecast for Other Companies Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 33: Europe & ROW - Other Companies Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 34: Europe & ROW - Forecast for Other Companies Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 15 35: Japan - Other Companies Coronary Stent Revenue (Million US$), 2008 - 2012
  • Figure 15 36: Japan - Forecast for Other Companies Coronary Stent Revenue (Million US$), 2013 - 2017
  • Figure 16 1: Worldwide - Peripheral Stent Market (Million US$), 2010 - 2012
  • Figure 16 2: Worldwide - Forecast for Peripheral Stent Market (Million US$), 2013 - 2017
  • Figure 16 3: Worldwide - Peripheral Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 16 4: Worldwide - Forecast for Peripheral Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 16 5: Worldwide - Peripheral Stent Market Share (Percent), 2010 - 2012
  • Figure 16 6: Worldwide - Forecast for Peripheral Stent Market Share (Percent), 2013 - 2017
  • Figure 17 1: Worldwide - Endovascular Stent Graft Market (Million US$), 2010 - 2012
  • Figure 17 2: Worldwide - Forecast for Endovascular Stent Graft Market (Million US$), 2013 - 2017
  • Figure 17 3: Worldwide - Endovascular Stent Graft Sales Unit (Thousand), 2010 - 2012
  • Figure 17 4: Worldwide - Forecast for Endovascular Stent Graft Sales Unit (Thousand), 2013 - 2017
  • Figure 17 5: Worldwide - Carotid Stent Market (Million US$), 2008 - 2012
  • Figure 17 6: Worldwide - Forecast for Carotid Stent Market (Million US$), 2013 - 2017
  • Figure 17 7: Worldwide - Carotid Stent Sales Unit (Thousand), 2008 - 2012
  • Figure 17 8: Worldwide - Forecast for Carotid Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 17 9: Worldwide - Renal & Related Stent Market (Million US$), 2002 - 2012
  • Figure 17 10: Worldwide - Forecast for Renal & Related Stent Market (Million US$), 2013 - 2017
  • Figure 17 11: Worldwide - Renal & Related Stent Sales Unit (Thousand), 2002 - 2012
  • Figure 17 12: Worldwide - Forecast for Renal & Related Stent Sales Unit (Thousand), 2013 - 2017
  • Figure 17 13: Worldwide - Femoral & Related Stent Market (Million US$), 2002 - 2012
  • Figure 17 14: Worldwide - Forecast for Femoral & Related Stent Market (Million US$), 2013 - 2017
  • Figure 17 15: Worldwide - Femoral & Related Stent Sales Unit (Thousand), 2002 - 2012
  • Figure 17 16: Worldwide - Forecast for Femoral & Related Stent Sales Unit (Thousand), 2013 -2017
  • Figure 18 1: Worldwide - Ventricular Assist Device Market (Million US$), 2010 - 2012
  • Figure 18 2: Worldwide - Forecast for Ventricular Assist Device Market (Million US$), 2013 - 2017
  • Figure 18 3: Worldwide - Ventricular Assist Device Sales Unit (Thousand), 2010 - 2012
  • Figure 18 4: Worldwide - Forecast for Ventricular Assist Device Sales Unit (Thousand), 2013 - 2017
  • Figure 18 5: Worldwide - Countries wise Ventricular Assist Device Market Share (Percent), 2010 - 2012
  • Figure 18 6: Worldwide - Forecast for Countries wise Ventricular Assist Device Market Share (Percent), 2013 - 2017
  • Figure 18 7: Worldwide - Application wise Ventricular Assist Device Market Share (Percent), 2010 - 2012
  • Figure 18 8: Worldwide - Forecast for Application wise Ventricular Assist Device Market Share (Percent), 2013 - 2017
  • Figure 19 1: United States - Ventricular Assist Device Market (Million US$), 2010 - 2012
  • Figure 19 2: United States - Forecast for Ventricular Assist Device Market (Million US$), 2013 - 2017
  • Figure 19 3: United States - Ventricular Assist Device Sales Unit (Thousand), 2010 - 2012
  • Figure 19 4: United States - Forecast for Ventricular Assist Device Sales Unit (Thousand), 2013 - 2017
  • Figure 19 5: Rest of the World - Ventricular Assist Device Market (Million US$), 2010 - 2012
  • Figure 19 6: Rest of the World - Forecast for Ventricular Assist Device Market (Million US$), 2013 - 2017
  • Figure 19 7: Rest of the World - Ventricular Assist Device Sales Unit (Thousand), 2010 - 2012
  • Figure 19 8: Rest of the World - Forecast for Ventricular Assist Device Sales Unit (Thousand), 2013 - 2017
  • Figure 20 1: Worldwide - Left Ventricular Assist Device Market (Million US$), 2010 - 2012
  • Figure 20 2: Worldwide - Forecast for Left Ventricular Assist Device Market (Million US$), 2013 - 2017
  • Figure 20 3: Worldwide - Left Ventricular Assist Device Sales Unit (Thousand), 2010 - 2012 239
  • Figure 20 4: Worldwide - Forecast for Left Ventricular Assist Device Sales Unit (Thousand), 2013 - 2017
  • Figure 20 5: Worldwide - Other Ventricular Assist Device Market (Million US$), 2010 - 2012
  • Figure 20 6: Worldwide - Forecast for Other Ventricular Assist Device Market (Million US$), 2013 - 2017
  • Figure 20 7: Worldwide - Other Ventricular Assist Device Sales Unit (Thousand), 2008 - 2012
  • Figure 20 8: Worldwide - Forecast for Other Ventricular Assist Device Sales Unit (Thousand), 2013 - 2017
  • Figure 23 1: United States - American Adults, by weight category (Percent), 2008 - 2012
  • Figure 23 2: India - Urban & Rural Coronary Heart Disease Cases (Million), 2000, 2005, 2010, 2020

List of Tables:

  • Table 21 1: Clinical Trial - The Partner Trial: Placement of Aortic Transcatheter Valve Trial
  • Table 21 2: Clinical Trial - The Partner II Trial: Placement of Aortic Transcatheter Valve Trial
  • Table 21 3: Clinical Trial - Risk Stratification & Benefits with Cardiac Resynchronization Therapy (CRT)
  • Table 21 4: Clinical Trial - Comparison between FFR Guided Revascularization versus Conventional Strategy in Acute STEMI Patients with MVD
  • Table 21 5: Clinical Trial - FAME II - FFR Guided PCI plus Optimal Medical Treatment (OMT) verses OMT Alone in Patients with Stable Coronary Artery Disease
  • Table 21 6: Clinical Trial - Prevent: Promus BTK
  • Table 21 7: Clinical Trial - Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) Post Approval Registry
  • Table 21 8: Clinical Trial - Supernova Clinical Stenting Trial
  • Table 21 9: Clinical Trial - Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents (BESS)
  • Table 21 10: Clinical Trial - Safety and Efficacy Continued Access Study of the Medtronic CoreValve System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
  • Table 21 11: Clinical Trial - Utility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillators
  • Table 21 12: Clinical Trial - Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System - The Engager European Pivotal Trial
  • Table 21 13: Clinical Trial - Adenosine Testing to Determine the Need for Pacing Therapy (ADEPT-ILR)
  • Table 21 14: Clinical Trial - Resolute Integrity US (RI-US)
  • Table 21 15: Clinical Trial - Efficacy of the ATP Switch Automatic Programming in Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) Implanted Patients
  • Table 21 16: Clinical Trial - Safety & Effectiveness Study of Perceval S Valve for Extended CE Mark (CAVALIER)
  • Table 21 17: Clinical Trial - Freedom SOLO Stentless Heart Valve
  • Table 21 18: Clinical Trial - Acute Optimization of Cardiac Resynchronization Therapy (CRT)Using Echocardiography and SonR (SonR Access)
  • Table 21 19: Clinical Trial - Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions (PRISON-IV)
  • Table 21 20: Clinical Trial - Study of the Orsiro Drug Eluting Stent System
  • Table 22 1: Worldwide - Merger & Acquisitions in Cardiac Implants Market (Million US$), 2000 - 2012
  • Table 23 1: United States - Obese Among Various Demographic Groups (Percent), 2008 - 2012
  • Table 23 2: United States - Annual Deaths & estimates of smoking attributable mortality (SAM), years of potentials life lost (YPLL) & productivity losses, by sex & cause of death, Male (2000 - 2004)
  • Table 23 3: United States - Annual Deaths & estimates of smoking attributable mortality (SAM), years of potentials life lost (YPLL) & productivity losses, by sex & cause of death, Female (2000 - 2004)
Back to Top